Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Serum neurofilament light chain predicts long-term prognosis in Guillain-Barré syndrome patients

View ORCID ProfileLorena Martín-Aguilar, View ORCID ProfilePol Camps-Renom, Cinta Lleixà, View ORCID ProfileElba Pascual-Goñi, Jordi Diaz-Manera, View ORCID ProfileRicard Rojas-García, Noemí de Luna, Eduard Gallardo, Elena Cortés-Vicente, Laia Muñoz, View ORCID ProfileDaniel Alcolea, View ORCID ProfileAlberto Lleó, Carlos Casasnovas, Christian Homedes, View ORCID ProfileGerardo Gutiérrez-Gutiérrez, María Concepción Jimeno-Montero, View ORCID ProfileJosé Berciano, Maria José Sedano Tous, Tania Garcia-Sobrino, Julio Pardo-Fernandez, Celedonio Márquez-Infante, Iñigo Rojas-Marcos, Ivonne Jericó Pascual, Eugenia Martínez-Hernández, Germán Morís de la Tassa, View ORCID ProfileCristina Domínguez-González, View ORCID ProfileIsabel Illa, View ORCID ProfileLuis Querol
doi: https://doi.org/10.1101/2020.03.24.20042200
Lorena Martín-Aguilar
1Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lorena Martín-Aguilar
Pol Camps-Renom
2Department of Neurology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Pol Camps-Renom
Cinta Lleixà
1Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elba Pascual-Goñi
1Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Elba Pascual-Goñi
Jordi Diaz-Manera
1Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Spain
3Centro para la Investigación Biomédica en Red en Enfermedades Raras (CIBERER)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ricard Rojas-García
1Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Spain
3Centro para la Investigación Biomédica en Red en Enfermedades Raras (CIBERER)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ricard Rojas-García
Noemí de Luna
1Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Spain
3Centro para la Investigación Biomédica en Red en Enfermedades Raras (CIBERER)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eduard Gallardo
1Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Spain
3Centro para la Investigación Biomédica en Red en Enfermedades Raras (CIBERER)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elena Cortés-Vicente
1Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Spain
3Centro para la Investigación Biomédica en Red en Enfermedades Raras (CIBERER)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laia Muñoz
4Department of Neurology, Sant Pau Memory Unit, Hospital de la Santa Creu i Sant Pau - IIB Sant Pau, Universitat Autònoma de Barcelona, Spain
5Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas, CIBERNED, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Alcolea
4Department of Neurology, Sant Pau Memory Unit, Hospital de la Santa Creu i Sant Pau - IIB Sant Pau, Universitat Autònoma de Barcelona, Spain
5Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas, CIBERNED, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Daniel Alcolea
Alberto Lleó
4Department of Neurology, Sant Pau Memory Unit, Hospital de la Santa Creu i Sant Pau - IIB Sant Pau, Universitat Autònoma de Barcelona, Spain
5Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas, CIBERNED, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alberto Lleó
Carlos Casasnovas
3Centro para la Investigación Biomédica en Red en Enfermedades Raras (CIBERER)
6Neuromuscular Unit, Department of Neurology, Bellvitge University Hospital, Barcelona, Spain
7Neurometabolic Diseases Group, Bellvitge Biomedical Research Institute (IDIBELL)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian Homedes
6Neuromuscular Unit, Department of Neurology, Bellvitge University Hospital, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerardo Gutiérrez-Gutiérrez
8Hospital Universitario Infanta Sofía, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gerardo Gutiérrez-Gutiérrez
María Concepción Jimeno-Montero
8Hospital Universitario Infanta Sofía, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
José Berciano
5Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas, CIBERNED, Spain
9Department of Neurology, Hospital Universitario Marqués de Valdecilla (IDIVAL), University of Cantabria, Santander, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for José Berciano
Maria José Sedano Tous
9Department of Neurology, Hospital Universitario Marqués de Valdecilla (IDIVAL), University of Cantabria, Santander, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tania Garcia-Sobrino
10Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julio Pardo-Fernandez
10Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Celedonio Márquez-Infante
11Hospital Universitario Virgen del Rocío, Sevilla, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Iñigo Rojas-Marcos
12Hospital Universitario Reina Sofia, Córdoba, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ivonne Jericó Pascual
13Complejo Hospitalario de Navarra, Navarra, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eugenia Martínez-Hernández
14Hospital Clínic de Barcelona, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Germán Morís de la Tassa
15Hospital Universitario Central de Asturias, Oviedo, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cristina Domínguez-González
16Hospital Universitario 12 de Octubre, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Cristina Domínguez-González
Isabel Illa
1Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Spain
3Centro para la Investigación Biomédica en Red en Enfermedades Raras (CIBERER)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Isabel Illa
Luis Querol
1Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Spain
3Centro para la Investigación Biomédica en Red en Enfermedades Raras (CIBERER)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Luis Querol
  • For correspondence: lquerol@santpau.cat
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Objective To study baseline serum neurofilament light chain (sNfL) levels as a prognostic biomarker in Guillain-Barré syndrome (GBS).

Methods We measured NfL using SiMoA in serum (98 samples) and CSF (24 samples) of GBS patients prospectively included in the International GBS Outcome Study (IGOS) in Spain and compared them with controls (HC). We performed multivariable regression to analyze the association between sNfL levels and functional outcome at one year.

Results GBS patients had higher NfL levels than HC in serum (55.49pg/mL vs 9.13pg/mL, p<0,0001) and CSF (1308.5pg/mL vs 440.24pg/mL, p=0.034). Patients with preceding diarrhea had higher sNfL than patients with respiratory symptoms or no preceding infection (134.90pg/mL vs 47.86pg/mL vs 38.02pg/mL, p=0.016). sNfL levels correlated with GDS and R-ODS scales. Patients with pure motor variant and Miller- Fisher syndrome showed higher sNfL levels than patients with sensory-motor GBS (162.18pg/mL vs 95.50pg/mL vs 38.02pg/mL; p=0.025). AMAN patients had higher sNfL levels than other variants (190.55pg/mL vs 46.79pg/mL, p=0.013). sNfL returned to normal levels at one year. High baseline sNfL levels were associated with inability to run (OR=1.65, 95% CI 1.14-2.40, p=0.009) and lower R-ODS (β −2.60, 95% β −4.66-(−0.54), p=0.014) at one year. Cut-off points predicting clinically relevant outcomes at one year with high specificity were calculated: inability to walk independently (>319pg/mL), inability to run (>248pg/mL) and ability to run (<34pg/mL).

Conclusion Baseline sNfL levels are increased in patients with GBS, they are associated with disease severity and axonal variants and they have an independent prognostic value in GBS patients.

Competing Interest Statement

Luis Querol has provided expert testimony for Grifols, Sanofi-Genzyme, Novartis, UCB, Roche and CSL Behring and received research funds from Novartis Spain, Sanofi-Genzyme and Grifols. Lorena Martín-Aguilar has received speaking honoraria from Roche. Elba Pascual-Goñi has received speaking honoraria from Roche and Biogen. Jordi Díaz-Manera has provided expert testimony for PTC and Sanofi-Genzyme, has been external advisor for Sanofi, Sarepta and Audentes and received research funds from Sanofi-Genzyme and Boehringer. Daniel Alcolea participated in advisory boards from Fujirebio-Europe and Roche Diagnostics and received speaker honoraria from Fujirebio-Europe, Nutricia and from Krka Farmacéutica S.L. Gerardo Gutiérrez-Gutiérrez has received speaking honoraria from Sanofi-Genzyme, Takeda and has provided expert testimony por Biogen and CSL Behring. The other authors report no disclosures.

Funding Statement

This work is supported by Fondo de Investigaciones Sanitarias (FIS), Instituto de Salud Carlos III, Spain and FEDER under grant FIS19/01407, personal grant Rio Hortega CM19/00042, personal grant SLT006/17/00131 of the Pla estratègic de recerca i innovació en salut (PERIS), Departament de Salut, Generalitat de Catalunya, and the ER20P3AC7624 project of the ACCI call of the CIBERER network, Madrid, Spain. Dr. Lleó is supported by Fundació Bancaria La Caixa. Dr. Alcolea is supported by Instituto Carlos III under grants PI18/00435 and INT19/00016 and personal grant SLT006/17/125 of the Pla estratègic de recerca i innovació en salut (PERIS).

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Funding: This work is supported by Fondo de Investigaciones Sanitarias (FIS), Instituto de Salud Carlos III, Spain and FEDER under grant FIS19/01407, personal grant Rio Hortega CM19/00042, personal grant SLT006/17/00131 of the Pla estratègic de recerca i innovació en salut (PERIS), Departament de Salut, Generalitat de Catalunya, and the ER20P3AC7624 project of the ACCI call of the CIBERER network, Madrid, Spain. Dr. Lleó is supported by Fundació Bancaria La Caixa. Dr. Alcolea is supported by Instituto Carlos III under grants PI18/00435 and INT19/00016 and personal grant SLT006/17/125 of the Pla estratègic de recerca i innovació en salut (PERIS).

  • Disclosures: Luis Querol has provided expert testimony for Grifols, Sanofi-Genzyme, Novartis, UCB, Roche and CSL Behring and received research funds from Novartis Spain, Sanofi-Genzyme and Grifols. Lorena Martín-Aguilar has received speaking honoraria from Roche. Elba Pascual-Goñi has received speaking honoraria from Roche and Biogen. Jordi Díaz-Manera has provided expert testimony for PTC and Sanofi-Genzyme, has been external advisor for Sanofi, Sarepta and Audentes and received research funds from Sanofi-Genzyme and Boehringer. Daniel Alcolea participated in advisory boards from Fujirebio-Europe and Roche Diagnostics and received speaker honoraria from Fujirebio-Europe, Nutricia and from Krka Farmacéutica S.L. Gerardo Gutiérrez-Gutiérrez has received speaking honoraria from Sanofi-Genzyme, Takeda and has provided expert testimony por Biogen and CSL Behring. The other authors report no disclosures.

Data Availability

Anonymized data not published within this article will be made available by request from any qualified investigator.

  • Abbreviations:
    AIDP
    Acute Inflammatory Demyelinating Polyneuropathy
    AMAN
    Acute Motor Axonal Neuropathy
    AMSAN
    Acute Motor-Sensory Axonal Neuropathy
    CI
    Coefficient Interval
    CSF
    cerebrospinal fluid
    GBS
    Guillain-Barré syndrome
    GeoMean
    geometric mean
    GDS
    GBS Disability Score
    HC
    Healthy controls
    IVIg
    Intravenous Immunoglobulin
    logNfL
    log-transformed neurofilament light chain
    MFS
    Miller-Fisher Syndrome
    MS
    Multiple sclerosis
    PLEX
    Plasma Exchange
    sNfL
    serum neurofilament light chain
    (NCS)
    nerve conduction studies
    OR
    Odds ratio
    R-ODS
    Rasch-built Overall Disability Scale.
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted March 30, 2020.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Serum neurofilament light chain predicts long-term prognosis in Guillain-Barré syndrome patients
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Serum neurofilament light chain predicts long-term prognosis in Guillain-Barré syndrome patients
    Lorena Martín-Aguilar, Pol Camps-Renom, Cinta Lleixà, Elba Pascual-Goñi, Jordi Diaz-Manera, Ricard Rojas-García, Noemí de Luna, Eduard Gallardo, Elena Cortés-Vicente, Laia Muñoz, Daniel Alcolea, Alberto Lleó, Carlos Casasnovas, Christian Homedes, Gerardo Gutiérrez-Gutiérrez, María Concepción Jimeno-Montero, José Berciano, Maria José Sedano Tous, Tania Garcia-Sobrino, Julio Pardo-Fernandez, Celedonio Márquez-Infante, Iñigo Rojas-Marcos, Ivonne Jericó Pascual, Eugenia Martínez-Hernández, Germán Morís de la Tassa, Cristina Domínguez-González, Isabel Illa, Luis Querol
    medRxiv 2020.03.24.20042200; doi: https://doi.org/10.1101/2020.03.24.20042200
    Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    Citation Tools
    Serum neurofilament light chain predicts long-term prognosis in Guillain-Barré syndrome patients
    Lorena Martín-Aguilar, Pol Camps-Renom, Cinta Lleixà, Elba Pascual-Goñi, Jordi Diaz-Manera, Ricard Rojas-García, Noemí de Luna, Eduard Gallardo, Elena Cortés-Vicente, Laia Muñoz, Daniel Alcolea, Alberto Lleó, Carlos Casasnovas, Christian Homedes, Gerardo Gutiérrez-Gutiérrez, María Concepción Jimeno-Montero, José Berciano, Maria José Sedano Tous, Tania Garcia-Sobrino, Julio Pardo-Fernandez, Celedonio Márquez-Infante, Iñigo Rojas-Marcos, Ivonne Jericó Pascual, Eugenia Martínez-Hernández, Germán Morís de la Tassa, Cristina Domínguez-González, Isabel Illa, Luis Querol
    medRxiv 2020.03.24.20042200; doi: https://doi.org/10.1101/2020.03.24.20042200

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Neurology
    Subject Areas
    All Articles
    • Addiction Medicine (62)
    • Allergy and Immunology (142)
    • Anesthesia (46)
    • Cardiovascular Medicine (415)
    • Dentistry and Oral Medicine (70)
    • Dermatology (48)
    • Emergency Medicine (144)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
    • Epidemiology (4861)
    • Forensic Medicine (3)
    • Gastroenterology (183)
    • Genetic and Genomic Medicine (676)
    • Geriatric Medicine (70)
    • Health Economics (192)
    • Health Informatics (630)
    • Health Policy (321)
    • Health Systems and Quality Improvement (206)
    • Hematology (85)
    • HIV/AIDS (156)
    • Infectious Diseases (except HIV/AIDS) (5343)
    • Intensive Care and Critical Care Medicine (331)
    • Medical Education (93)
    • Medical Ethics (24)
    • Nephrology (75)
    • Neurology (686)
    • Nursing (42)
    • Nutrition (115)
    • Obstetrics and Gynecology (126)
    • Occupational and Environmental Health (208)
    • Oncology (440)
    • Ophthalmology (140)
    • Orthopedics (36)
    • Otolaryngology (90)
    • Pain Medicine (35)
    • Palliative Medicine (16)
    • Pathology (129)
    • Pediatrics (194)
    • Pharmacology and Therapeutics (131)
    • Primary Care Research (84)
    • Psychiatry and Clinical Psychology (781)
    • Public and Global Health (1817)
    • Radiology and Imaging (325)
    • Rehabilitation Medicine and Physical Therapy (138)
    • Respiratory Medicine (255)
    • Rheumatology (86)
    • Sexual and Reproductive Health (69)
    • Sports Medicine (62)
    • Surgery (100)
    • Toxicology (23)
    • Transplantation (29)
    • Urology (37)